CanBas Competitors and Similar CompaniesClear all

CanBas's competitors and similar companies include CureVac.
CanBas
CanBas
CanBas (キャンバス) is a drug discovery company engaged in research and development of anti-cancer agents.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Founding Date
Founding Date
2000
Founding Date
2000
Type
Type
Public
Type
Public
Tags
Locations
Locations
HQ
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Employees
Employees
13
Employees
82517% decrease
Valuation ($)
Valuation ($)
109.6 m
Valuation ($)
648.3 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€535.2m (FY, 2024)
Cost of goods
Cost of goods
N/A
Cost of goods
€9.7m (FY, 2024)
Gross profit
Gross profit
N/A
Gross profit
€534.4m (FY, 2024)
Net income
Net income
(¥1.2b) (FY, 2025)
Net income
€162.2m (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease

CureVac is a biotechnology company offering messenger RNA (mRNA) technology.

View company